Sepragen
Union City, US · California corporation
Sepragen develops chromatography and bioreactor systems for large-scale pharmaceutical and biopharmaceutical manufacturing, including vaccine production, monoclonal antibodies, and viral vectors. The company serves pharmaceutical manufacturers and contract manufacturers requiring purification and bioprocessing equipment at production scale.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2024
▶$5MraisedOct 2024 · Manufacturing
- Vinit SaxenaExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2024
- Incorporated
- Corporation, California
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Companies competing with Sepragen for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2017 | $225K |
| National Science Foundation | Phase ISTTR | 2013 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Sepragen do?
- Sepragen develops chromatography and bioreactor systems for large-scale pharmaceutical and biopharmaceutical manufacturing, including vaccine production, monoclonal antibodies, and viral vectors. The company serves pharmaceutical manufacturers and contract manufacturers requiring purification and bioprocessing equipment at production scale.
- How much funding has Sepragen raised?
- Sepragen has disclosed $5M raised across 1 round.
- Where is Sepragen headquartered?
- Sepragen is headquartered in Union City, US.